Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2025-12-25 @ 4:03 AM
NCT ID:
NCT06542302
Eligibility Criteria:
Inclusion Criteria:
* Healthy asymptomatic adults will not have any complaints of current pain and impairments of neuromusculoskeletal systems within the last 6 months.
* For patients with CNP
* Pain was unilateral or bilateral between the superior nuchal line and 1st thoracic vertebra
* Neck pain persisting for 3 months and above
* Average pain intensity of last pain episode was between 2 and 8 based on the numeric rating scale (NRS).
Exclusion criteria:
◾For patients with CNP and healthy asymptomatic adults
* Acute or the first onset of neck pain
* Traumatic cause of pain
* Previous fracture or surgery of the spine
* Diagnosed cardiopulmonary diseases, for example, chronic obstructive pulmonary disease, pulmonary tuberculosis, asthma, chronic bronchitis, pulmonary emphysema
* Diagnosed gastrointestinal and abdominal conditions which may interfere daily activities within the past 6 months
* Medical conditions that may affect balance and study procedures (e.g. neurological diseases, vestibular disorders, malignant tumors)
* Metabolic diseases such as anemia and diabetes
* Smoking, plan to pregnant or in pregnancy
* Psychological disorders (affect questionnaire responses)
* Unable to walk independently
* Corrected visual abnormalities or individuals unable to wear contact lenses for vision correction due to the potential interference of wearing VR head-mounted display with glasses.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT06542302
Study Brief:
Protocol Section:
NCT06542302